Avant Immunotherapeutics Inc is : A biopharmaceutical company that uses novel applications of immunology to develop products for the prevention and treatment of diseases. As far as a business and a company today. As the name implies a company that harnesses. Awarded a subcontract to develop an oral combination vaccine against anthrax and plague for the us department of defense using the company's vaccine technologies. Jointly develop animal vaccines; avant will acquire megan health inc, animal vaccine. The name of the company that will be formed after the proposed merger between t cell sciences and virus research. Been awarded a contract to develop an oral vaccine for the u. Engaged in the discovery, development and commercialization of products that harness the human immune system to prevent and treat disease. Adding 20 new jobs to fall river's employment base. A late day gainer. Dropping. Teamed with pfizer to develop additional animal and food safety vaccines. Various products in >> preclinical development stages, which include etec for enterotoxigenic e. In early human studies of a vaccine against. Seeking a self-motivated individual to join our manufacturing group in the fall river facility. Formed in 1998 when t cell sciences and virus research institute merged. Webcast the following presentation. Developing a broad portfolio of vaccines including single dose, oral vaccines that protect against. Oral. Taken directly from the biotechwatch database. Human and veterinary use. The treatment and control of cancer, including canvaxin, an investigational. Agriculture to control plant. Patients with hemophilia, hepatitis c and multiple sclerosis. The treatment of cartilage. The treatment and control of cancer, will host a conference. The removal of fats, oils, and grease. Long-term. |
